Feds Fight Gilead's Win In Billion-Dollar HIV Patent Trial
The U.S. government urged a Delaware federal judge Tuesday to overturn a jury's verdict invalidating three federal patents on HIV treatments and clearing drugmaker Gilead Sciences Inc. of claims it infringed...To view the full article, register now.
Already a subscriber? Click here to view full article